Dashboard
Manage Tickers

CB Chubb Ltd

NYSE chubb.com


$ 277.09 $ 1.04 (0.38 %)    

Monday, 03-Nov-2025 14:42:23 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 631.14 $ -4.08 (-0.64 %)
DIA $ 473.46 $ -2.68 (-0.56 %)
SPY $ 682.66 $ -2.97 (-0.43 %)
TLT $ 89.64 $ 0.00 (0 %)
GLD $ 368.13 $ -0.60 (-0.16 %)
$ 276.94
$ 276.16
$ 277.01 x 40
$ 277.09 x 6
$ 273.45 - $ 277.62
$ 249.66 - $ 304.83
1,892,465
na
114.52B
$ 0.53
$ 9.80
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-27-2025 09-30-2025 10-Q
2 07-28-2025 06-30-2025 10-Q
3 04-28-2025 03-31-2025 10-Q
4 02-27-2025 01-01-1970 10-K
5 10-30-2024 09-30-2024 10-Q
6 07-26-2024 06-30-2024 10-Q
7 04-26-2024 03-31-2024 10-Q
8 02-23-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 07-28-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 10-28-2022 09-30-2022 10-Q
14 07-29-2022 06-30-2022 10-Q
15 04-29-2022 03-31-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 10-28-2021 09-30-2021 10-Q
18 07-29-2021 06-30-2021 10-Q
19 04-30-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 10-30-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 04-29-2020 03-31-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 10-31-2019 09-30-2019 10-Q
26 07-31-2019 06-30-2019 10-Q
27 05-02-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 10-30-2018 09-30-2018 10-Q
30 08-01-2018 06-30-2018 10-Q
31 05-02-2018 03-31-2018 10-Q
32 02-23-2018 12-31-2017 10-K
33 11-01-2017 09-30-2017 10-Q
34 08-03-2017 06-30-2017 10-Q
35 05-04-2017 03-31-2017 10-Q
36 02-28-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-05-2016 06-30-2016 10-Q
39 05-10-2016 03-31-2016 10-Q
40 02-26-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
10 Financials Stocks Whale Activity In Tod...
10/29/2025 17:35:30

ubs-maintains-neutral-on-chubb-raises-price-target-to-298
UBS Maintains Neutral on Chubb, Raises Pri...
10/27/2025 16:56:41

UBS analyst Brian Meredith maintains Chubb (NYSE:CB) with a Neutral and raises the price target from $292 to $298.

heres-how-much-1000-invested-in-chubb-5-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Chubb 5 ...
10/24/2025 21:00:30

keefe-bruyette--woods-maintains-outperform-on-chubb-raises-price-target-to-335
Keefe, Bruyette & Woods Maintains Outperfo...
10/23/2025 16:37:27

Keefe, Bruyette & Woods analyst Meyer Shields maintains Chubb (NYSE:CB) with a Outperform and raises the price target fr...

wells-fargo-maintains-equal-weight-on-chubb-raises-price-target-to-293
Wells Fargo Maintains Equal-Weight on Chub...
10/23/2025 13:15:08

Wells Fargo analyst Elyse Greenspan maintains Chubb (NYSE:CB) with a Equal-Weight and raises the price target from $277 to $...

chubb-ramps-up-buybacks-as-management-sees-stock-undervalued
Chubb Ramps Up Buybacks As Management Sees...
10/22/2025 18:45:15

Chubb Ltd. (CB) announced strong Q3 results, beating expectations on key metrics. Analysts reaffirm bullish outlook with $325 p...

jmp-securities-reiterates-market-outperform-on-chubb-maintains-325-price-target
JMP Securities Reiterates Market Outperfor...
10/22/2025 12:30:40

JMP Securities analyst Matthew J. Carletti reiterates Chubb (NYSE:CB) with a Market Outperform and maintains $325 price target.

chubb-q3-adj-eps-749-beats-615-estimate-sales-12934b-beat-12901b-estimate
Chubb Q3 Adj. EPS $7.49 Beats $6.15 Estima...
10/21/2025 20:11:40

Chubb (NYSE:CB) reported quarterly earnings of $7.49 per share which beat the analyst consensus estimate of $6.15 by 21.79 perc...

Core News & Articles
10 Financials Stocks Whale Activity In Tod...
10/21/2025 17:35:47

Core News & Articles
Earnings Scheduled For October 21, 2025
10/21/2025 08:32:17

a-glimpse-of-chubbs-earnings-potential
A Glimpse of Chubb's Earnings Potential
10/20/2025 14:03:48

chubbs-healthy-paws-collaborates-with-airvet-to-enhance-veterinary-care-availability-throughout-us
Chubb's Healthy Paws Collaborates With Air...
10/20/2025 12:28:05

Healthy Paws, a Chubb company and a leading provider of accident and illness pet insurance coverage for dogs and cats, today an...

11-analysts-have-this-to-say-about-chubb
11 Analysts Have This To Say About Chubb
10/09/2025 13:00:44

jp-morgan-maintains-neutral-on-chubb-raises-price-target-to-327
JP Morgan Maintains Neutral on Chubb, Rais...
10/09/2025 12:54:20

JP Morgan analyst Jimmy Bhullar maintains Chubb (NYSE:CB) with a Neutral and raises the price target from $321 to $327.

barclays-maintains-equal-weight-on-chubb-raises-price-target-to-310
Barclays Maintains Equal-Weight on Chubb, ...
10/08/2025 15:15:09

Barclays analyst Alex Scott maintains Chubb (NYSE:CB) with a Equal-Weight and raises the price target from $298 to $310.

wells-fargo-maintains-equal-weight-on-chubb-raises-price-target-to-277
Wells Fargo Maintains Equal-Weight on Chub...
10/08/2025 14:00:17

Wells Fargo analyst Elyse Greenspan maintains Chubb (NYSE:CB) with a Equal-Weight and raises the price target from $267 to $...

10-defensive-stocks-to-consider-buying-as-experts-get-skittish
10 Defensive Stocks To Consider Buying As ...
10/03/2025 17:06:57

evercore-isi-group-maintains-outperform-on-chubb-raises-price-target-to-315
Evercore ISI Group Maintains Outperform on...
10/01/2025 15:05:43

Evercore ISI Group analyst David Motemaden maintains Chubb (NYSE:CB) with a Outperform and raises the price target from $312...

100-invested-in-chubb-5-years-ago-would-be-worth-this-much-today
$100 Invested In Chubb 5 Years Ago Would B...
09/24/2025 21:34:06

jim-cramer-spotlights-these-undervalued-sp-500-stocks-with-growth-potential-amid-skyrocketing-market
Jim Cramer Spotlights These Undervalued S&...
09/23/2025 09:14:41

In a recent episode of "Mad Money," Jim Cramer identified several stocks in the S&P 500 that he believes are underv...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION